{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:12:51Z","timestamp":1776939171646,"version":"3.51.4"},"reference-count":172,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002017","name":"Children's Brain Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002017","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.wneu.2024.06.142","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T06:18:40Z","timestamp":1729059520000},"page":"573-581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Challenges and Outlooks in Precision Medicine: Expectations Versus Reality"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6718-142X","authenticated-orcid":false,"given":"Rachel E.","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1904-1040","authenticated-orcid":false,"given":"Jeffrey P.","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2024.06.142_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature07517","article-title":"Accurate whole human genome sequencing using reversible terminator chemistry","volume":"456","author":"Bentley","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.1181498","article-title":"Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays","volume":"327","author":"Drmanac","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1126\/science.1162986","article-title":"Real-time DNA sequencing from single polymerase molecules","volume":"323","author":"Eid","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature03959","article-title":"Genome sequencing in microfabricated high-density picolitre reactors","volume":"437","author":"Margulies","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib6","unstructured":"Yan RE, Greenfield JP. Emergence of precision medicine within neurological surgery: promise and opportunity. World Neurosurg."},{"key":"10.1016\/j.wneu.2024.06.142_bib7","unstructured":"Uribe-Cardenas R, Greenfield JP. Reimagining the N-of-1 trial within pediatric neuro-oncology: a shifting paradigm. World Neurosurg."},{"key":"10.1016\/j.wneu.2024.06.142_bib8","series-title":"Cramming More Components onto Integrated Circuits","author":"Moore","year":"1965"},{"key":"10.1016\/j.wneu.2024.06.142_bib9","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib11","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM198809013190901","article-title":"Genetic alterations during colorectal-tumor development","volume":"319","author":"Vogelstein","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","article-title":"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis","volume":"9","author":"Phillips","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.wneu.2024.06.142_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.wneu.2024.06.142_bib15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.wneu.2024.06.142_bib16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0092-8674(88)90469-2","article-title":"Mapping proteinDNA interactions in\u00a0vivo with formaldehyde: evidence that histone H4 is retained on a highly transcribed gene","volume":"53","author":"Solomon","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2024.06.142_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nprot.2006.98","article-title":"Chromatin immunoprecipitation and microarray-based analysis of protein location","volume":"1","author":"Lee","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.wneu.2024.06.142_bib18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.21856","article-title":"An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites","volume":"6","author":"Skene","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.wneu.2024.06.142_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature11232","article-title":"The accessible chromatin landscape of the human genome","volume":"489","author":"Thurman","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib20","doi-asserted-by":"crossref","first-page":"21.29.21","DOI":"10.1002\/0471142727.mb2129s109","article-title":"ATAC-seq: a method for assaying chromatin accessibility genome-wide","volume":"109","author":"Buenrostro","year":"2015","journal-title":"Curr Protoc Mol Biol"},{"key":"10.1016\/j.wneu.2024.06.142_bib21","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1101\/gad.281964.116","article-title":"The second decade of 3C technologies: detailed insights into nuclear organization","volume":"30","author":"Denker","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.wneu.2024.06.142_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jamaoncol.2017.4182","article-title":"Cancer drugs approved based on biomarkers and not tumor type\u2014FDA approval of pembrolizumab for mismatch repair-deficient solid cancers","volume":"4","author":"Prasad","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib23","article-title":"Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors","volume":"4","author":"Rajappa","year":"2022","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.wneu.2024.06.142_bib24","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.wneu.2024.06.142_bib25","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.4049\/jimmunol.158.4.1825","article-title":"Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse","volume":"158","author":"Henninger","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.wneu.2024.06.142_bib26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/neuros\/nyz212","article-title":"ABC Transporter inhibition plus dexamethasone enhances the efficacy of convection enhanced delivery in H3.3K27M mutant diffuse intrinsic pontine glioma","volume":"86","author":"Tsvankin","year":"2020","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2024.06.142_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1084\/jem.20180199","article-title":"Immune cells and CNS physiology: microglia and beyond","volume":"216","author":"Norris","year":"2019","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ni.3666","article-title":"The movers and shapers in immune privilege of the CNS","volume":"18","author":"Engelhardt","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.wneu.2024.06.142_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccr.2006.11.020","article-title":"A\u00a0perivascular niche for brain tumor stem cells","volume":"11","author":"Calabrese","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.wneu.2024.06.142_bib30","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ccell.2018.03.020","article-title":"A\u00a0glial signature and Wnt7 signaling regulate glioma-vascular interactions and tumor microenvironment","volume":"33","author":"Griveau","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.wneu.2024.06.142_bib31","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1158\/1078-0432.CCR-16-1508","article-title":"Malignant astrocytic tumor progression potentiated by JAK-mediated recruitment of myeloid cells","volume":"23","author":"Rajappa","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2024.06.142_bib32","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1007\/s00018-014-1625-0","article-title":"Developmental and pathological angiogenesis in the central nervous system","volume":"71","author":"Vallon","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.wneu.2024.06.142_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fonc.2018.00239","article-title":"Beyond the blood:brain barrier: the importance of central nervous system (CNS) pharmacokinetics for the treatment of CNS tumors, including diffuse intrinsic pontine glioma","volume":"8","author":"Warren","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib35","first-page":"5564","article-title":"Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer","volume":"16","author":"Lockman","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2024.06.142_bib36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/neuonc\/nou141","article-title":"Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study","volume":"17","author":"Morikawa","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib37","doi-asserted-by":"crossref","first-page":"e84236","DOI":"10.1371\/journal.pone.0084236","article-title":"Xenograft tumors vascularized with murine blood vessels may overestimate the effect of anti-tumor drugs: a pilot study","volume":"8","author":"Dong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2024.06.142_bib38","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2024.06.142_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.wneu.2024.06.142_bib40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1704795","article-title":"Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer","volume":"377","author":"Peters","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib41","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(18)30322-X","article-title":"Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial","volume":"19","author":"Souweidane","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1227\/01.NEU.0000043696.83722.8D","article-title":"Prolonged convection-enhanced delivery into the rat brainstem","volume":"52","author":"Occhiogrosso","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2024.06.142_bib43","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1073\/pnas.91.6.2076","article-title":"Convection-enhanced delivery of macromolecules in the brain","volume":"91","author":"Bobo","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.wneu.2024.06.142_bib44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cne.901030304","article-title":"Effects of high intensity ultrasound on the central nervous system of the cat","volume":"103","author":"Barnard","year":"1955","journal-title":"J\u00a0Comp Neurol"},{"key":"10.1016\/j.wneu.2024.06.142_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1227\/01.NEU.0000360379.95800.2F","article-title":"Transcranial magnetic resonance imaging- guided focused ultrasound surgery of brain tumors: initial findings in 3 patients","volume":"66","author":"McDannold","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2024.06.142_bib46","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.wneu.2020.08.050","article-title":"Cranial MR-guided focused ultrasound: clinical challenges and future directions","volume":"145","author":"Chazen","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2024.06.142_bib47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.wneu.2018.01.123","article-title":"Laser-induced thermal therapy in neuro-oncology: a review","volume":"112","author":"Ashraf","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2024.06.142_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148613","article-title":"Hyperthermic laser ablation of recurrent glioblastoma leads to temporary disruption of the peritumoral blood brain barrier","volume":"11","author":"Leuthardt","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2024.06.142_bib49","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2967\/jnumed.118.218792","article-title":"A\u00a0distinct advantage to intraarterial delivery of (89)Zr-bevacizumab in PET imaging of mice with and without osmotic opening of the blood-brain barrier","volume":"60","author":"Lesniak","year":"2019","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib50","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3171\/2021.3.PEDS20738","article-title":"Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial","volume":"28","author":"McCrea","year":"2021","journal-title":"J\u00a0Neurosurg Pediatr"},{"key":"10.1016\/j.wneu.2024.06.142_bib51","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1158\/1078-0432.CCR-20-3760","article-title":"Opening of the blood-brain barrier using low-intensity pulsed ultrasound enhances responses to immunotherapy in preclinical glioma models","volume":"27","author":"Sabbagh","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2024.06.142_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2021.01.023","article-title":"ImmunoPET-informed sequence for focused ultrasound-targeted mCD47 blockade controls glioma","volume":"331","author":"Sheybani","year":"2021","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.wneu.2024.06.142_bib53","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.1114518108","article-title":"Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma","volume":"108","author":"Agemy","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.wneu.2024.06.142_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev-med-050311-201823","article-title":"Antibody-drug conjugates in cancer therapy","volume":"64","author":"Sievers","year":"2013","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnen\/61.3.215","article-title":"The WHO classification of tumors of the nervous system","volume":"61","author":"Kleihues","year":"2002","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.wneu.2024.06.142_bib56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib57","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1200\/JCO.2009.26.5983","article-title":"Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers","volume":"28","author":"Von Hoff","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib58","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1158\/1078-0432.CCR-12-1627","article-title":"Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative","volume":"18","author":"Tsimberidou","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2024.06.142_bib59","article-title":"Implementation and clinical utility of an integrated academic-community regional molecular tumor board","volume":"1","author":"Burkard","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.wneu.2024.06.142_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/npjgenmed.2016.19","article-title":"Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care","volume":"1","author":"Rennert","year":"2016","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00098","article-title":"Comparison of treatment recommendations by molecular tumor boards worldwide","volume":"2","author":"Rieke","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib64","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O'Brien","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib65","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib66","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.wneu.2024.06.142_bib67","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/neuonc\/noq007","article-title":"Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas","volume":"12","author":"Dougherty","year":"2010","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib68","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","article-title":"Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial","volume":"20","author":"Fangusaro","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib69","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11060-016-2333-4","article-title":"Combined BRAF(V600E) and MEK blockade for BRAF(V600E)-mutant gliomas","volume":"131","author":"Zhang","year":"2017","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib70","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1158\/1078-0432.CCR-18-3694","article-title":"Agnostic-histology approval of new drugs in oncology: are we already there?","volume":"25","author":"Hierro","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2024.06.142_bib71","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2024.06.142_bib72","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1101\/gad.1596707","article-title":"Malignant astrocytic glioma: genetics, biology, and paths to treatment","volume":"21","author":"Furnari","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.wneu.2024.06.142_bib73","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib74","doi-asserted-by":"crossref","first-page":"eaav1898","DOI":"10.1126\/science.aav1898","article-title":"The chromatin accessibility landscape of primary human cancers","volume":"362","author":"Corces","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib75","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature16490","article-title":"Insulator dysfunction and oncogene activation in IDH mutant gliomas","volume":"529","author":"Flavahan","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib76","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib77","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome","volume":"1","author":"Hopkins","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.wneu.2024.06.142_bib78","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/nbt1196-1516","article-title":"Genomic sciences and the medicine of tomorrow","volume":"14","author":"Drews","year":"1996","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.wneu.2024.06.142_bib79","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd2199","article-title":"How many drug targets are there?","volume":"5","author":"Overington","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.wneu.2024.06.142_bib80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A\u00a0comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.wneu.2024.06.142_bib81","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","article-title":"Click chemistry: diverse chemical function from a few good reactions","volume":"40","author":"Kolb","year":"2001","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.wneu.2024.06.142_bib82","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1359-6446(03)02933-7","article-title":"The growing impact of click chemistry on drug discovery","volume":"8","author":"Kolb","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.wneu.2024.06.142_bib83","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/348552a0","article-title":"Phage antibodies: filamentous phage displaying antibody variable domains","volume":"348","author":"McCafferty","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib84","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0022-2836(91)90498-U","article-title":"By-passing immunization. Human antibodies from V-gene libraries displayed on phage","volume":"222","author":"Marks","year":"1991","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.wneu.2024.06.142_bib85","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nbt1135","article-title":"Human antibodies from transgenic animals","volume":"23","author":"Lonberg","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.wneu.2024.06.142_bib86","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng0594-13","article-title":"Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs","volume":"7","author":"Green","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.wneu.2024.06.142_bib87","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri1837","article-title":"Potent antibody therapeutics by design","volume":"6","author":"Carter","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.wneu.2024.06.142_bib88","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1479-5876-3-38","article-title":"The natural history of EGFR and EGFRvIII in glioblastoma patients","volume":"3","author":"Heimberger","year":"2005","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib89","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S1470-2045(17)30619-8","article-title":"Act IV: the final act for rindopepimut?","volume":"18","author":"Gerstner","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib90","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/noy032","article-title":"CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges","volume":"20","author":"Bagley","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-med-062315-120245","article-title":"CAR T cell therapy for solid tumors","volume":"68","author":"Newick","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib92","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/neuonc\/noy202","article-title":"Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma","volume":"21","author":"Kieran","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib93","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/mt.2009.73","article-title":"Herpes simplex virus oncolytic therapy for pediatric malignancies","volume":"17","author":"Friedman","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.wneu.2024.06.142_bib94","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fonc.2013.00028","article-title":"Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy","volume":"3","author":"Friedman","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib95","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0140-6736(92)90606-4","article-title":"Gene therapy for cancer","volume":"339","author":"Gutierrez","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.wneu.2024.06.142_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add8280","article-title":"Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma","volume":"15","author":"Zhang","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib97","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.wneu.2024.06.142_bib98","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ymthe.2019.03.009","article-title":"In\u00a0vitro-transcribed mRNA therapeutics: out of the shadows and into the spotlight","volume":"27","author":"Kariko","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.wneu.2024.06.142_bib99","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","article-title":"Exagamglogene autotemcel for severe sickle cell disease","volume":"390","author":"Frangoul","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib100","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa2309673","article-title":"Exagamglogene autotemcel for transfusion-dependent \u03b2-thalassemia","volume":"390","author":"Locatelli","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib101","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2015.12.025","article-title":"Uncovering the roles of long noncoding RNAs in neural development and glioma progression","volume":"625","author":"Ramos","year":"2016","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.wneu.2024.06.142_bib102","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib103","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/neuonc\/noz077","article-title":"Immunotherapy for pediatric brain tumors: past and present","volume":"21","author":"Foster","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib104","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/287795a0","article-title":"Mutations affecting segment number and polarity in Drosophila","volume":"287","author":"Nusslein-Volhard","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib105","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib106","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature02371","article-title":"A\u00a0large-scale RNAi screen in human cells identifies new components of the p53 pathway","volume":"428","author":"Berns","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib107","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib108","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib109","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A\u00a0programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.1246981","article-title":"Genetic screens in human cells using the CRISPR-Cas9 system","volume":"343","author":"Wang","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib111","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib112","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","article-title":"Prioritization of cancer therapeutic targets using CRISPR\u2013Cas9 screens","volume":"568","author":"Behan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib113","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2024.06.142_bib114","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41588-021-00819-w","article-title":"A\u00a0first-generation pediatric cancer dependency map","volume":"53","author":"Dharia","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.wneu.2024.06.142_bib115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat8288","article-title":"A\u00a0genome-wide net to catch and understand cancer","volume":"10","author":"Sanjana","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib116","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature15521","article-title":"BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis","volume":"527","author":"Canver","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib117","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah7111","article-title":"CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells","volume":"355","author":"Liu","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib118","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.wneu.2024.06.142_bib119","first-page":"2615","article-title":"Proteasome inhibitors: a novel class of potent and effective antitumor agents","volume":"59","author":"Adams","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2024.06.142_bib120","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1073\/pnas.1311846111","article-title":"High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells","volume":"111","author":"Mathews Griner","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.wneu.2024.06.142_bib121","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw0064","article-title":"Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening","volume":"11","author":"Lin","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib122","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/j.celrep.2019.02.063","article-title":"Modeling patient-derived glioblastoma with cerebral organoids","volume":"26","author":"Linkous","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.wneu.2024.06.142_bib123","doi-asserted-by":"crossref","first-page":"10326","DOI":"10.1021\/acs.analchem.8b02133","article-title":"Reconstituting Glioma perivascular niches on a chip for insights into chemoresistance of glioma","volume":"90","author":"Lin","year":"2018","journal-title":"Anal Chem"},{"key":"10.1016\/j.wneu.2024.06.142_bib124","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s43586-021-00093-4","article-title":"High-content CRISPR screening","volume":"2","author":"Bock","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"10.1016\/j.wneu.2024.06.142_bib125","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2217\/epi-2022-0093","article-title":"Developments in high-throughput functional epigenomics: CRISPR-single-cell assay for transposase-accessible chromatin using sequencing screens","volume":"14","author":"Yan","year":"2022","journal-title":"Epigenomics"},{"key":"10.1016\/j.wneu.2024.06.142_bib126","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib127","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib128","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2024.06.142_bib129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature16071","article-title":"Brain tumour cells interconnect to a functional and resistant network","volume":"528","author":"Osswald","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","article-title":"Glutamatergic synaptic input to glioma cells drives brain tumour progression","volume":"573","author":"Venkataramani","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib131","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","article-title":"Neuronal activity promotes glioma growth through neuroligin-3 secretion","volume":"161","author":"Venkatesh","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2024.06.142_bib132","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-020-1952-2","article-title":"PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis","volume":"578","author":"Yu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib133","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s40478-019-0803-6","article-title":"Immune landscapes associated with different glioblastoma molecular subtypes","volume":"7","author":"Martinez-Lage","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.wneu.2024.06.142_bib134","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/2326-6066.CIR-13-0028","article-title":"Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas","volume":"1","author":"Doucette","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.wneu.2024.06.142_bib135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.wneu.2024.06.142_bib136","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85841","article-title":"Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype","volume":"1","author":"Gabrusiewicz","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.wneu.2024.06.142_bib137","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pages","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.wneu.2024.06.142_bib138","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib139","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.wneu.2024.06.142_bib140","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib141","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2024.06.142_bib142","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nature11287","article-title":"A\u00a0restricted cell population propagates glioblastoma growth after chemotherapy","volume":"488","author":"Chen","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib143","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature23666","article-title":"Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy","volume":"549","author":"Lan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib144","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature11249","article-title":"Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors","volume":"487","author":"Wilson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib145","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature11183","article-title":"Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion","volume":"487","author":"Straussman","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib146","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in\u00a0vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2024.06.142_bib147","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor antigen escape from CAR T-cell therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.wneu.2024.06.142_bib148","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.acra.2016.11.021","article-title":"Role of imaging in the era of precision medicine","volume":"24","author":"Giardino","year":"2017","journal-title":"Acad Radiol"},{"key":"10.1016\/j.wneu.2024.06.142_bib149","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature14541","article-title":"Probabilistic machine learning and artificial intelligence","volume":"521","author":"Ghahramani","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jmri.26907","article-title":"Imaging signatures of glioblastoma molecular characteristics: a radiogenomics review","volume":"52","author":"Fathi Kazerooni","year":"2020","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.wneu.2024.06.142_bib151","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/neuonc\/nov127","article-title":"Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques","volume":"18","author":"Macyszyn","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib152","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1158\/1078-0432.CCR-16-1871","article-title":"In\u00a0vivo detection of EGFRvIII in glioblastoma via perfusion magnetic resonance imaging signature consistent with deep peritumoral infiltration: the phi-index","volume":"23","author":"Bakas","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2024.06.142_bib153","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa7582","article-title":"Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities","volume":"7","author":"Itakura","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib154","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/neuonc\/noy033","article-title":"In\u00a0vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature","volume":"20","author":"Akbari","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib155","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2024.06.142_bib156","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2214\/AJR.17.18754","article-title":"Imaging genetic heterogeneity in glioblastoma and other glial tumors: review of current methods and future directions","volume":"210","author":"Chow","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.wneu.2024.06.142_bib157","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1007\/s00330-017-4751-x","article-title":"Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma","volume":"27","author":"Cui","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.wneu.2024.06.142_bib158","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11060-017-2602-x","article-title":"The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma","volume":"135","author":"Liu","year":"2017","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib159","doi-asserted-by":"crossref","DOI":"10.1038\/srep35142","article-title":"Multiparametric MRI-based differentiation of WHO grade II\/III glioma and WHO grade IV glioblastoma","volume":"6","author":"Wiestler","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.wneu.2024.06.142_bib160","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1007\/s00330-021-07991-x","article-title":"Radiogenomics of diffuse intrinsic pontine gliomas (DIPGs): correlation of histological and biological characteristics with multimodal MRI features","volume":"31","author":"Calmon","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.wneu.2024.06.142_bib161","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3174\/ajnr.A5899","article-title":"MR imaging-based radiomic signatures of distinct molecular subgroups of medulloblastoma","volume":"40","author":"Iv","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.wneu.2024.06.142_bib162","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3174\/ajnr.A3990","article-title":"MRI surrogates for molecular subgroups of medulloblastoma","volume":"35","author":"Perreault","year":"2014","journal-title":"AJNR Am J Neuroradioy"},{"key":"10.1016\/j.wneu.2024.06.142_bib163","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/neuonc\/noy093","article-title":"Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients","volume":"21","author":"Dasgupta","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib164","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/neuonc\/noy111","article-title":"Magnetic resonance imaging surrogates of molecular subgroups in atypical teratoid\/rhabdoid tumor","volume":"20","author":"Nowak","year":"2018","journal-title":"Neuro Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.wneu.2024.06.142_bib165","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1471-2105-7-S1-S7","article-title":"ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context","volume":"7","author":"Margolin","year":"2006","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.wneu.2024.06.142_bib166","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature08712","article-title":"The transcriptional network for mesenchymal transformation of brain tumours","volume":"463","author":"Carro","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib167","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41592-020-0958-x","article-title":"Predicting 3D genome folding from DNA sequence with Akita","volume":"17","author":"Fudenberg","year":"2020","journal-title":"Nat Methods"},{"key":"10.1016\/j.wneu.2024.06.142_bib168","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41568-024-00694-7","article-title":"A\u00a0guide to artificial intelligence for cancer researchers","volume":"24","author":"Perez-Lopez","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.wneu.2024.06.142_bib169","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-019-0882-3","article-title":"Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid","volume":"565","author":"Miller","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2024.06.142_bib170","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/neuonc\/noab023","article-title":"A\u00a0serum-based DNA methylation assay provides accurate detection of glioma","volume":"23","author":"Sabedot","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.06.142_bib171","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/14737159.2017.1374854","article-title":"Liquid biopsy for brain tumors","volume":"17","author":"Shankar","year":"2017","journal-title":"Exp Rev Mol Diagn"},{"key":"10.1016\/j.wneu.2024.06.142_bib172","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1158\/1078-0432.CCR-20-3083","article-title":"TERT promoter mutation analysis for blood-based diagnosis and monitoring of gliomas","volume":"27","author":"Muralidharan","year":"2021","journal-title":"Clin Cancer Res"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875024011045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875024011045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:16:41Z","timestamp":1762561001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875024011045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":172,"alternative-id":["S1878875024011045"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2024.06.142","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and Outlooks in Precision Medicine: Expectations Versus Reality","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2024.06.142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}